Precipio Inc. (PRPO)
6.27
0.01 (0.15%)
At close: Mar 28, 2025, 3:44 PM
5.97
-4.78%
After-hours: Mar 28, 2025, 04:05 PM EDT
Precipio Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service revenue, net Revenue | 11.21M | 9.52M | 7.08M | 21.78M | 2.66M | 2.06M | 1.15M | 1.98M | 2.14M | 967K | 839K | 1.96M | 2.02M | 2.12M | 1.97M | 1.59M | 1.1M | 900K | 878K | 757K | 640K | 531K | 303K |
| Service revenue, net Revenue Growth | +17.75% | +34.42% | -67.47% | +719.95% | +29.18% | +78.63% | -41.87% | -7.43% | +121.20% | +15.26% | -57.26% | -2.68% | -4.90% | +7.56% | +23.87% | +44.73% | +22.22% | +2.51% | +15.98% | +18.28% | +20.53% | +75.25% | n/a |
| Diagnostic Testing Revenue | 4.6M | 3.91M | 2.82M | n/a | n/a | n/a | 1.97M | n/a | n/a | 1.93M | 2.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Diagnostic Testing Revenue Growth | +17.65% | +38.57% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.41% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|
| All Other Countries Revenue | 3.89M | 3.25M | 2.94M |
| All Other Countries Revenue Growth | +19.83% | +10.48% | n/a |
| Italy Revenue | 1.26M | 1.53M | 2.52M |
| Italy Revenue Growth | -17.78% | -39.38% | n/a |
| United States Revenue | 21.05M | 20.12M | 22.73M |
| United States Revenue Growth | +4.64% | -11.48% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 2.63M | 2.99M | 2.5M | 3.33M | 3.66M | 3.77M | 2.55M | 3.28M | 2.82M | 5.13M | 3.55M | 2.68M | 2.6M | 2.34M | 2.73M | 2.81M | 2.43M | 2.33M | -4.56M | 2.39M | 2.47M | 2.1M | 2.08M | 2.83M | 2.36M | 2.18M | 2.51M | 2.54M | 777K | 1.62M | 1.8M | 1.25M | 1.44M | 1.7M | -5.21M | 3.1M | 5.07M | 5.05M |
| Selling, General, and Administrative Revenue Growth | -100.00% | -12.22% | +19.90% | -25.08% | -9.01% | -2.97% | +47.92% | -22.22% | +16.18% | -44.95% | +44.51% | +32.41% | +3.04% | +11.34% | -14.36% | -2.85% | +15.60% | +4.38% | -151.01% | -290.88% | -3.08% | +17.64% | +0.58% | -26.35% | +20.06% | +8.26% | -13.12% | -1.34% | +227.03% | -52.04% | -10.00% | +43.77% | -12.81% | -15.73% | -132.67% | -268.06% | -38.83% | +0.38% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | 2.7M | n/a | n/a | n/a | 1.7M | n/a | n/a | n/a | 2.3M | n/a | n/a | n/a | 2.2M | n/a | n/a | n/a | 2.79M | n/a | n/a | n/a | 1.03M | 8K | 57K | n/a | -134K | n/a | n/a | 134K | 357K | 393K | 402K | 270K | 149K | 561K | 576K | 567K |
| Research and Development Revenue Growth | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | +12837.49% | -85.96% | n/a | -100.00% | n/a | n/a | -100.00% | -62.46% | -9.16% | -2.24% | +48.89% | +81.21% | -73.44% | -2.60% | +1.59% | n/a |